In the last trading session, 7.61 million Molecular Templates Inc (NASDAQ:MTEM) shares changed hands as the company’s beta touched 1.13. With the company’s per share price at $0.75 changed hands at -$0.18 or -19.35% during last session, the market valuation stood at $4.94M. MTEM’s last price was a discount, traded about -765.33% off its 52-week high of $6.49. The share price had its 52-week low at $0.29, which suggests the last value was 61.33% up since then. When we look at Molecular Templates Inc’s average trading volume, we note the 10-day average is 26.58 million shares, with the 3-month average coming to 4.00 million.
Molecular Templates Inc (NASDAQ:MTEM) trade information
Instantly MTEM was in red as seen at the end of in last trading. With action -48.98%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -79.89%, with the 5-day performance at -48.98% in the red. However, in the 30-day time frame, Molecular Templates Inc (NASDAQ:MTEM) is -44.85% down. Looking at the short shares, we see there were 0.14 million shares sold at short interest cover period of 3.02 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Molecular Templates Inc (MTEM) estimates and forecasts
Year-over-year growth is forecast to reach -78.50% down from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 330k. 1 analysts are of the opinion that Molecular Templates Inc’s revenue for the current quarter will be 340k. The company’s revenue for the corresponding quarters a year ago was 6.8M and 7.02M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -95.10%. The estimates for the next quarter sales put growth at -95.20%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 34.83%.
MTEM Dividends
Molecular Templates Inc is expected to release its next quarterly earnings report in November.
Molecular Templates Inc (NASDAQ:MTEM)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.96% of Molecular Templates Inc shares while 56.12% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 58.43%.
